Home

The Cancer Genomics and Tumor Immunotherapy Symposium: A Clinical Perspective is a key educational event, jointly hosted by the Cancer Genomics Program (CGP) and the Tumor Immunotherapy Program (TIP) at the Princess Margaret Cancer Centre. The objective of this Symposium is to provide a clinical and translational perspective on cancer genomics and tumor immunotherapy by highlighting emerging therapies and technologies as they apply to precision cancer medicine at the point of care. Participants will learn about new research on mechanisms of resistance and response, emerging therapies and technologies aimed at increasing the personalized approach to treatment, and genomic applications in the clinic.

This one-day symposium will be held at the MaRS Discovery District in downtown Toronto:

MaRS Discovery District 
101 College Street, 
Toronto, ON  
M5G 1L7

 

Confirmed speakers include:

Trey Ideker, PhD, University of California San Diego

Benjamin Haibe-Kains, PhD, Princess Margaret Cancer Centre

Anna Goldenberg, PhD, SickKids

Jennifer Knox, MD, Princess Margaret Cancer Centre 

Daniel Renouf, MD, British Columbia Cancer Agency

Jeffrey Bluestone, PhD, University of California San Francisco

Bertrand Routy, MD, PhD, Centre Hospitalier de l'Université de Montréal

Michele Ardolino, PhD, The Ottawa Hospital

Prasad Adusumilli, MD, Memorial Sloan Kettering Cancer Center

 

Target Audience for the 2019 Cancer Genomics and Tumor Immunotherapy Symposium:

  • Oncologists: Medical, Radiation, Surgical
  • Pathologists
  • Clinical Geneticists
  • Genetic Counselors
  • Laboratory Directors
  • Laboratory Technicians
  • Oncology Nurses
  • Bioinformaticians
  • Basic and Translational Scientists
  • Basic, Translational and Clinical Trainees
  • Pharmaceutical Representatives

 

Topics to be discussed in a presentation or panel include:

  • Network Medicine in Precision Oncology
  • PharmacoDB and Data Science in Cancer Genomics
  • AI and Cancer Genomics (Drug Response Prediction)
  • Controlling Anti-Tumor Immunity
  • Microbiome in Cancer
  • The Role of PD-1 in NK-mediated tumor attack
  • CAR-T Therapy in Solid Tumors